bevacizumab,cisplatin,atezolizumab,gemcitabine
roche
[]
imbrave151 bev doesn't add benefit to gem+cis+io atezo. we need to better understand how we can prime the immune system to recognize cholangiocarcinoma. #gi23 
GI Oncologist at @IUCancerCenter. @uw_hemeoncpc and @UChicagomed alum. Tweets are my own.